中文 | English
Return
Total: 11 , 1/2
Show Home Prev Next End page: GO
Author:(Yanjiang HAN)

1.Value of the dual phase 18F-FDG PET/CT in the diagnosis of recurrent and metastatic bladder cancer after surgery

Hongsheng LI ; Hubin WU ; Qiaoyu WANG ; Yanjiang HAN ; Quanshi WANG

The Journal of Practical Medicine 2014;(9):1450-1453

2.Complementary value of 11C-choline PET/CT to 18F-FDG PET/CT for diagnosing nasopharyngeal and hepatocellular carcinoma

Hubing WU ; Quanshi WANG ; Yanjiang HAN ; Wenlan ZHOU ; Hongsheng LI

Chinese Journal of Nuclear Medicine and Molecular Imaging 2013;(3):161-166

3.Effects of dexmedetomidine on perioperative cardiac adverse events in elderly patients with coronary heart disease

Junmei SHEN ; Yanjiang SUN ; Ding HAN ; Kangsheng ZHU ; Wei ZHAO

Journal of Central South University(Medical Sciences) 2017;42(5):553-557

4.Establishment of a diagnostic model for charactering solitary pulmonary nodule based on 18F-FDGPET/CT and clinical data

Wenjuan LIU ; Quanshi WANG ; Hubing WU ; Yanjiang HAN ; Wenlan ZHOU ; Hongsheng LI

Chinese Journal of Nuclear Medicine and Molecular Imaging 2016;36(3):211-215

5.Value of 18F-FDG PET/CT in the evaluation of treatment response and prognosis for patients with recurrent uterine cervical cancer

Dandan CHEN ; Hubing WU ; Quanshi WANG ; Yanjiang HAN ; Wenlan ZHOU ; Hongsheng LI ; Ying TIAN

Chinese Journal of Nuclear Medicine and Molecular Imaging 2015;35(3):168-172

6.Value of dual-phase (18)F-FDG PET/CT in preoperative staging of bladder cancer.

Hongsheng LI ; Hubing WU ; Qiaoyu WANG ; Yanjiang HAN ; Quanshi WANG

Journal of Southern Medical University 2014;34(4):500-503

7.Tumor targeting efficacy of a novel PET radiotracer (1)8F-AlF-NOTA-PRGD2 in mice.

Hubing WU ; Quanshi WANG ; Yanjiang HAN ; Wenlan ZHOU ; Hongsheng LI ; Ying TIAN ; Qiaoyu WANG

Journal of Southern Medical University 2014;34(1):51-55

8.Relationship between the SUV max of primary lesion on 18F-FAPI-42 PET/CT imaging and the clinicopathological characteristics of patients with gastric cancer

Lilan FU ; Fei XIE ; Ye DONG ; Yanjiang HAN ; Jinmei ZHONG ; Caixia XIAO ; Ganghua TANG ; Hubing WU ; Wenlan ZHOU

Chinese Journal of Nuclear Medicine and Molecular Imaging 2023;43(6):331-336

9.Preliminary study on the evaluation of Langerhans cell histiocytosis using F-18-fluoro-deoxy-glucose PET/CT.

Wenlan ZHOU ; Hubing WU ; Yanjiang HAN ; Shaobo WANG ; Ye DONG ; Quanshi WANG

Chinese Medical Journal 2014;127(13):2458-2462

10.Efficient lung cancer-targeted drug delivery a nanoparticle/MSC system.

Xusheng WANG ; Haiyan CHEN ; Xiaowei ZENG ; Wenpeng GUO ; Yu JIN ; Shan WANG ; Ruiyun TIAN ; Yanjiang HAN ; Ling GUO ; Jimin HAN ; Yaojiong WU ; Lin MEI

Acta Pharmaceutica Sinica B 2019;9(1):167-176

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 11 , 1/2 Show Home Prev Next End page: GO